About this trial
This study will prospective enroll 80 subjects to evaluate the comparison of image quality, proportion of high-quality images, and image noise between the Spectral Precise Image (SPI) intelligent denoising for low-dose scans on the Spectral CT Verida system and iDose4 reconstructions after low-dose and routine-dose scans.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
18 ≤ age ≤ 75 years.
18 kg/m² ≤ BMI ≤ 28 kg/m².
Conscious, able to cooperate, and competent to perform study procedures. Voluntarily agrees to participate in this clinical study and has signed the informed consent form.
Women of childbearing potential must have a negative pregnancy test and have no plans to become pregnant during the next 6 months.
Disqualifiers
Persons without full civil capacity.
Pregnant or breastfeeding women.
Any other conditions that, in the investigator's judgment, make the subject unsuitable for participation in this clinical study.
Trial design
Parallel
Treatments tested in this trial
CT Radiation Scan
RadiationUse investigated CT do radiation scan
Treatment groups
Trial outcomes
Primary outcomes
The rate of good-excellent scores ≥3
Image quality will be assessed by 2 radiologists using Likert-scale on a range from 1(poor) to 5(Excellent),and calculate the rate of ≥3 with FAS,PSS SS as the datasets analysis.
Secondary outcomes
Objective outcome:Image Noise
Will use FAS,PSS,SS do the image noise (parameters record)datasets analysis.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Philips Clinical & Medical Affairs Global
Lead sponsor
Qilu Hospital of Shandong University
Collaborator
This trial is not recruiting at the moment. You can still explore other options: